HuR/Cx40 downregulation causes coronary microvascular dysfunction in type 2 diabetes
Cabrera, Jody Tori O
Lee, Yun Sok
Scott, Brian T
Ashton, Anthony W
Rao, Jaladanki N
Yuan, Jason X-J
PublisherAmerican Society for Clinical Investigation
MetadataShow full item record
AbstractPatients with diabetes with coronary microvascular disease (CMD) exhibit higher cardiac mortality than patients without CMD. However, the molecular mechanism by which diabetes promotes CMD is poorly understood. RNA-binding protein human antigen R (HuR) is a key regulator of mRNA stability and translation; therefore, we investigated the role of HuR in the development of CMD in mice with type 2 diabetes. Diabetic mice exhibited decreases in coronary flow velocity reserve (CFVR; a determinant of coronary microvascular function) and capillary density in the left ventricle. HuR levels in cardiac endothelial cells (CECs) were significantly lower in diabetic mice and patients with diabetes than the controls. Endothelial-specific HuR-KO mice also displayed significant reductions in CFVR and capillary density. By examining mRNA levels of 92 genes associated with endothelial function, we found that HuR, Cx40, and Nox4 levels were decreased in CECs from diabetic and HuR-KO mice compared with control mice. Cx40 expression and HuR binding to Cx40 mRNA were downregulated in CECs from diabetic mice. Cx40-KO mice exhibited decreased CFVR and capillary density, whereas endothelium-specific Cx40 overexpression increased capillary density and improved CFVR in diabetic mice. These data suggest that decreased HuR contributes to the development of CMD in diabetes through downregulation of gap junction protein Cx40 in CECs.
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/17102
- Downregulation of connexin40 is associated with coronary endothelial cell dysfunction in streptozotocin-induced diabetic mice.
- Authors: Makino A, Platoshyn O, Suarez J, Yuan JX, Dillmann WH
- Issue date: 2008 Jul
- Overexpression of p53 due to excess protein O-GlcNAcylation is associated with coronary microvascular disease in type 2 diabetes.
- Authors: Si R, Zhang Q, Tsuji-Hosokawa A, Watanabe M, Willson C, Lai N, Wang J, Dai A, Scott BT, Dillmann WH, Yuan JX, Makino A
- Issue date: 2020 May 1
- Interplay between RNA-binding protein HuR and Nox4 as a novel therapeutic target in diabetic kidney disease.
- Authors: Shi Q, Lee DY, Féliers D, Abboud HE, Bhat MA, Gorin Y
- Issue date: 2020 Jun
- Coronary Microvascular Dysfunction Restored After Surgery in Inflammatory Bowel Disease: A Prospective Observational Study.
- Authors: Kakuta K, Dohi K, Yamamoto T, Fujimoto N, Shimoyama T, Umegae S, Ito M
- Issue date: 2021 May 4
- Peripheral Reactive Hyperemia Index and Coronary Microvascular Function in Women With no Obstructive CAD: The iPOWER Study.
- Authors: Michelsen MM, Mygind ND, Pena A, Aziz A, Frestad D, Høst N, Prescott E, Steering Committee of the iPOWER Study.
- Issue date: 2016 Apr